Source: https://tradeasduck.com/ideas/abbv/
Retrieved: 2026-11-19

[Archive](https://tradeasduck.com/ideas/) › ABBV

# ABBV trade ideas: every closed DuckWise idea on AbbVie Inc.

DuckWise has published 1 idea on AbbVie Inc. (ABBV, Stock) that has closed between October 2020 and November 2020. Each is listed below with the levels published before the position was taken and its result at close — 1 in profit, 0 at a loss.

**1** closed idea

**1 / 0** in profit / at a loss

**+22.45%** average result

**34 days** typical holding period

| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2020 | Nov 23, 2020 | Long | 83.59 | — | 100 | 102.36 | +22.45% | 34 |

Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. [How results are counted](https://tradeasduck.com/methodology/).

## ABBV questions and answers

### Has DuckWise published trade ideas on ABBV?

Yes. DuckWise has published 1 idea on AbbVie Inc. (ABBV) that closed between October 2020 and November 2020: 1 closed in profit and 0 at a loss. The average result was +22.45% from the published entry to the published close, dividends included.

### What was the latest closed DuckWise idea on ABBV?

A long idea opened on October 20, 2020 with an entry of $83.59 and a price projection of $100.00. It closed on November 23, 2020 at $102.36, a result of +22.45% after 34 days.

### How long did DuckWise hold its ABBV ideas?

The typical ABBV idea was held about 34 days from entry to close. DuckWise ideas are swing and position trades, not day trades.

### Is there an open DuckWise idea on ABBV right now?

Not at the moment. When DuckWise publishes a new idea on ABBV, app subscribers get a push notification; it appears on this page once it closes.

### Is this page a stock forecast for ABBV or a recommendation to buy it?

No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where ABBV will trade. The research is general and impersonal, not a recommendation to buy or sell ABBV or any other security.

## More trade ideas on the record
- [AAL](https://tradeasduck.com/ideas/aal/) American Airlines Group Inc. · 11 ideas
- [AAN](https://tradeasduck.com/ideas/aan/) The Aaron's Company, Inc. · 1 idea
- [AAPL](https://tradeasduck.com/ideas/aapl/) Apple Inc. · 14 ideas
- [ADBE](https://tradeasduck.com/ideas/adbe/) Adobe Inc. · 13 ideas
- [ALB](https://tradeasduck.com/ideas/alb/) Albemarle Corporation · 1 idea
- [AMAT](https://tradeasduck.com/ideas/amat/) Applied Materials, Inc. · 3 ideas
- [AMZN](https://tradeasduck.com/ideas/amzn/) Amazon.com, Inc. · 25 ideas
- [TSLA](https://tradeasduck.com/ideas/tsla/) Tesla, Inc. · 22 ideas
- [CRM](https://tradeasduck.com/ideas/crm/) Salesforce, Inc. · 18 ideas
- [LRCX](https://tradeasduck.com/ideas/lrcx/) Lam Research Corporation · 16 ideas
- [GOOG](https://tradeasduck.com/ideas/goog/) Alphabet Inc. · 15 ideas
- [ON](https://tradeasduck.com/ideas/on/) ON Semiconductor Corporation · 15 ideas
- [AMD](https://tradeasduck.com/ideas/amd/) Advanced Micro Devices, Inc. · 14 ideas
- [JD](https://tradeasduck.com/ideas/jd/) JD.com, Inc. · 14 ideas

[Every ticker in the archive](https://tradeasduck.com/ideas/) · [Track record by year](https://tradeasduck.com/)

## About AbbVie Inc.

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. Pays a dividend yield of 2.35% annually.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell ABBV or any other security.

---
Model-portfolio results calculated from published entry and close levels plus dividends — not the returns of any real account; fees, taxes and slippage are not included; past results are not a reliable indicator of future results. General, impersonal research — not investment advice and not a recommendation to buy or sell any security.
